OakChart

Sanofi ADR

SNYHealthcare·Drug Manufacturers - General·France·Large·NASD·Nov 11 • 3:59 PM ET

48.43+0.20 (0.41%)
2026-11-12 05:38 CET
Market cap
115,431.94 USD m
Revenue, TTM
53,469.84 USD m
Net income, TTM
4,692.30 USD m
Free cash flow, TTM
12,054.72 USD m
EPS diluted, TTM
1.94
P/E
24.94
Compare

Price

SNY against its 20, 50 and 200-day averages
2050200
40.0042.5045.0047.507.5M15.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SNYclose 48.4320-day 43.8450-day 42.52200-day 44.3448.4352w low

8.1% under the 52-week high of 52.68 on 13 Nov 2025. 52-week low 39.07 on 13 Oct 2026. Last 15 sessions, 18.5% high to low

Volume 0.72× normal · the line is the 50-bar volume average

Profile

SNY
52-week range, 69% of the way up
39.0752.68

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France.

Employees76493
IPOJul 01, 2002
Beta0.25
ATR, 14d1.05
Rel volume0.72
Short float0.52%
Insider own0.00%
Inst own7.87%

Snapshot

6 groups

Valuation

Index-
Market Cap115.43B
Enterprise Value135.54B
Income4.69B
Sales53.47B
Book/sh32.59
Cash/sh3.05
Dividend Est.2.38 (4.91%)
Dividend TTM2.42 (4.99%)
Dividend Ex-DateMay 04, 2026
Dividend Gr. 3/5Y8.45% 5.14%
Payout73.36%
Employees76493
IPOJul 01, 2002

Ratios

P/E24.94
Forward P/E9.16
PEG1.26
P/S2.16
P/B1.49
P/C15.90
P/FCF9.58
EV/EBITDA6.03
EV/Sales2.53
Quick Ratio0.64
Current Ratio0.99
Debt/Eq0.34
LT Debt/Eq0.24
Option/ShortYes / Yes

Earnings

EPS (ttm)1.94
EPS next Y5.29
EPS next Q0.96
EPS this Y6.08%
EPS next Y6.69%
EPS next 5Y7.29%
EPS past 3/5Y-11.86% -15.52%
Sales past 3/5Y2.90% 3.69%
EPS Y/Y TTM-30.90%
Sales Y/Y TTM23.68%
EPS Q/Q-32.22%
Sales Q/Q18.71%
EarningsOct 30 BMO
EPS/Sales Surpr.3.11% 3.35%

Ownership

Insider Own0.00%
Insider Trans-
Inst Own7.87%
Inst Trans-0.68%
ROA3.12%
ROE5.70%
ROIC4.80%
Gross Margin66.29%
Oper. Margin27.17%
Profit Margin8.78%
SMA2010.46%
SMA5013.90%
SMA2009.23%
Trades-

Technical

Shs Outstand2.43B
Shs Float2.38B
Short Float0.52%
Short Ratio3.66
Short Interest12.29M
52W High52.68 -8.07%
52W Low39.07 23.96%
Volatility2.33% 1.90%
ATR (14)1.05
RSI (14)77.05
Beta0.25
Rel Volume0.72
Avg Volume3.36M
Volume2,432,444

Performance

Perf Week2.02%
Perf Month23.80%
Perf Quarter10.62%
Perf Half Y14.17%
Perf YTD-0.06%
Perf Year-6.31%
Perf 3Y5.47%
Perf 5Y-5.55%
Perf 10Y18.64%
Recom1.90
Target Price52.56
Prev Close48.23
Price48.43
Change %0.41%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 09, 2026UpgradeBBNP Paribas ExaneNeutral → Outperform$57+17.7%
Oct 09, 2026InitiatedWWolfe ResearchPeer Perform
Sep 09, 2026InitiatedRRBC Capital MktsSector Perform
May 01, 2026DowngradeMMorgan StanleyOverweight → Equal-Weight
Apr 20, 2026DowngradeBBNP Paribas ExaneOutperform → Neutral$50+3.2%
Feb 12, 2026DowngradeBBofA SecuritiesBuy → Neutral
Jan 27, 2026InitiatedCCitigroupNeutral
Jan 16, 2026DowngradeUUBSBuy → Neutral
Jan 06, 2026DowngradeBBarclaysOverweight → Equal Weight
Dec 09, 2025DowngradeGGuggenheimBuy → Neutral

Peers

Mkt cap
TickerCompanyMkt cap
GSKGSK Plc ADR101.43B
PFEPfizer Inc167.86B
MRKMerck & Co Inc362.83B
NVONovo Nordisk ADR137.48B
AZNAstrazeneca plc287.66B
NVSNovartis AG ADR293.47B
ABBVAbbvie Inc521.41B
BMYBristol-Myers Squibb Co128.59B
JNJJohnson & Johnson675.03B
LLYLilly(Eli) & Co1352.12B

Held by

AUM
TickerCompanyAUM
AVDEAvantis International Equity ETFAUM: 19.73B
PPHVanEck Pharmaceutical ETFAUM: 1.09B
FVDFirst Trust Value Line Dividend Index FundAUM: 8.21B
FENIFidelity Enhanced International ETFAUM: 11.73B
PIDInvesco International Dividend Achievers ETFAUM: 881.07M
GMOIGMO International Value ETFAUM: 737.83M
BUSABrandes U.S. Value ETFAUM: 419.48M
IDVZPolen International Dividend Income FundAUM: 206.39M
QQQJInvesco NASDAQ Next Gen 100 ETFAUM: 1.17B
FLVAmerican Century Focused Large Cap Value ETFAUM: 408.50M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2024Q12024-04-250.9540.9250.48711,79411,41110
2023Q42024-02-010.8990.937-0.23811,82412,6309
2023Q32023-10-271.3491.3721.06313,43313,1619
2023Q22023-07-280.9600.9250.63511,78811,53210
2023Q12023-04-271.1891.1040.88111,96111,4208
2022Q42023-02-030.9280.9230.63012,43812,05812
2022Q32022-10-281.4331.3130.82613,07212,01514
2022Q22022-07-280.8790.8390.47710,90910,12412
2022Q12022-04-281.0150.9610.84210,57210,33511
2021Q42022-02-040.7850.7540.51211,43611,65211
2021Q32021-10-281.2661.1431.07412,18111,96611
2021Q22021-07-290.8160.7710.57310,63010,14811
2021Q12021-04-280.9680.8260.75210,57910,40310
2020Q42021-02-050.7270.690-11,18911,379-
2020Q32020-10-291.0691.050-11,07711,487-
2020Q22020-07-290.7050.650-9,0359,86010

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY3.2703.2581.29441,30941,322
2020FY3.5043.4895.56143,34144,645
2021FY3.7333.6482.92443,21043,795
2022FY4.4844.4113.50049,28147,736
2023FY4.3914.4142.32346,64148,988
2024FY3.7143.8202.39446,50445,509
2025FY4.6704.5342.41653,81353,037
2026FY-4.954--56,667
2027FY-5.286--60,254
2028FY-5.768--63,429
2029FY-6.278--65,696
2030FY-6.741--68,106

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026FYS2026-11-112011556,66752,94759,054
2026FYS2026-11-062111556,73552,94759,054
2026FYS2026-11-052110656,55252,94759,054
2026FYS2026-11-04218756,32052,94759,054
2026FYS2026-11-03216956,14252,68659,054
2026FYS2026-11-022141155,94552,68658,779
2026FYS2026-10-302141155,94952,68658,779
2026FYS2026-10-212001555,89152,94758,779
2026FYS2026-10-202001555,88652,94758,779
2026FYS2026-10-192001455,95152,94758,779
2026FYS2026-10-162001356,04752,94759,004
2026FYS2026-10-152001256,07952,94759,004
2026FYS2026-10-142001256,12252,94759,004
2026FYS2026-10-132021056,26352,94759,004

Estimate history

EPS, annual1.682.031.2945.5612.9243.52.3232.3942.396
Period201720182019202020212022202320242025
EPS, quarterly
Period
Sales, annual39558.92140657.71640433.97641085.81844632.78245188.74340884.54944436.93849235.342
Period201720182019202020212022202320242025
Sales, quarterly
Period
Shares, annual2507.6922490.9092507.6532501.3812505.0852505.2812502.6992507.1832415.079
Period201720182019202020212022202320242025
Shares, quarterly
Period

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue53,469.8449,235.3444,436.9440,884.5545,188.7444,632.7841,085.8240,433.9840,657.72
Cost of Goods Sold Incl. D&A18,022.6816,893.6816,319.4715,886.9916,663.2016,485.0915,895.8015,971.6816,189.71
Gross Profit35,447.1632,341.6628,117.4724,997.5528,525.5428,147.6925,190.0124,462.3024,468.01
Selling, General and Administrative Excl. Other20,917.6919,507.4717,836.0016,581.0717,987.4317,902.2816,908.1017,666.2218,477.24
Research and Development9,453.448,844.677,996.947,031.587,046.786,724.296,301.786,732.286,948.73
Other Operating Expense0.000.00-1.08-2.16-4.200.00-4.56-6.72-3.54
Operating Income14,529.4712,834.1910,282.558,418.6510,542.3210,245.418,286.476,802.795,994.31
Interest Expense653.17574.45644.69564.34414.08427.88527.81608.87555.66
Unusual Expense5,159.903,968.081,957.862,269.26838.68983.411,295.014,689.652,627.30
Net Income Before Taxes6,336.936,968.977,245.166,758.0510,953.259,217.0915,706.573,158.525,196.80
Income Taxes1,403.211,177.111,302.361,099.492,108.251,841.532,059.93155.58567.46
Consolidated Net Income4,656.155,616.936,007.715,511.538,916.477,421.6614,055.883,288.355,218.03
Net Income From Continuing Operations4,594.335,574.055,944.975,472.618,797.717,355.4714,014.853,253.665,095.34
Net Income4,692.305,871.996,014.205,838.028,797.717,355.4714,014.853,253.665,095.34
EPS (Recurring)3.443.532.942.963.733.205.922.602.76
EPS (Basic, Before Extraordinaries)1.952.412.402.333.512.945.591.302.04
EPS (Diluted)1.942.402.392.323.502.925.561.292.03
EBITDA22,486.3419,291.9114,209.0913,262.0514,429.8813,946.1912,016.4710,994.3810,080.96
Non-Operating Income (Expense)-2,379.47-1,322.69-434.841,173.011,663.69382.969,242.911,654.252,385.45
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense285.18264.93221.02206.60193.12211.98224.89194.61222.90
Price To Earnings Ratio24.8424.8426.4613.8916.2117.078.8138.7021.32
Price To Sales Ratio1.922.412.733.062.692.822.983.122.68
Gross Margin66.2965.6963.2761.1463.1363.0761.3160.5060.18
Operating Margin27.1726.0723.1420.5923.3322.9520.1716.8214.74
Net Margin8.7811.9313.5314.2819.4716.4834.118.0512.53
Shares Outstanding2,428.202,415.082,507.182,502.702,505.282,505.092,501.382,507.652,490.91
Market Capitalization115,431.94115,431.94120,361.82124,711.90121,468.25125,780.06122,094.04125,819.27108,544.10

Income statement, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S22023S12022S2
Total Revenue25,786.4927,683.3521,722.4521,511.5622,923.9124,754.0621,813.8123,519.82
Cost of Goods Sold Incl. D&A8,472.249,550.457,295.797,654.408,567.969,804.058,000.678,837.54
Gross Profit17,314.2518,132.9014,426.6613,857.1614,355.9514,950.0113,813.1414,682.28
Selling, General and Administrative Excl. Other10,232.4810,685.218,981.038,545.309,385.099,784.589,049.929,220.64
Research and Development4,642.644,810.794,059.654,298.633,699.783,824.043,450.313,606.97
Other Operating Expense0.000.000.000.000.00---
Operating Income7,081.787,447.695,445.635,311.864,970.865,165.434,763.235,461.64
Interest Expense311.45341.71235.91312.84331.82323.45246.37220.94
Unusual Expense1,910.723,249.18797.29803.221,154.362,100.79666.72-57.77
Net Income Before Taxes3,312.843,024.093,912.204,285.642,960.473,153.354,579.536,838.96
Income Taxes1,016.02387.20776.54802.14500.44943.30788.831,531.37
Consolidated Net Income2,299.162,357.003,228.503,562.532,445.982,141.903,734.515,317.73
Net Income From Continuing Operations2,252.502,341.843,201.193,518.142,427.612,131.083,706.415,256.92
Net Income2,261.832,430.473,406.523,587.422,427.612,131.083,706.415,256.92
EPS (Recurring)1.491.941.611.651.291.431.662.07
EPS (Basic, Before Extraordinaries)0.941.011.391.430.970.851.482.10
EPS (Diluted)0.941.001.381.430.970.851.482.09
EBITDA10,465.7712,020.577,412.667,658.736,551.088,401.006,773.127,095.37
Non-Operating Income (Expense)-1,546.77-832.70-500.2289.85-524.22412.15729.401,540.49
Stock Option Compensation Expense160.98124.21140.0783.54137.4497.80129.6776.77
Price To Earnings Ratio24.8412.0520.1026.4620.7913.8915.0516.21
Price To Sales Ratio1.922.382.752.732.552.692.982.70
Gross Margin67.1465.5066.4164.4262.6260.3963.3262.43
Operating Margin27.4626.9025.0724.6921.6820.8721.8423.22
Net Margin8.778.7815.6816.6810.598.6116.9922.35
Shares Outstanding2,428.202,415.082,434.192,507.182,502.072,502.702,502.982,505.28
Market Capitalization115,431.94117,160.77117,705.38120,361.82121,582.39124,711.90135,200.07121,468.25

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments9,012.737,824.249,745.2213,592.5011,483.4517,025.7010,935.407,916.3112,386.25
Short Term Receivables12,972.9711,006.3312,195.3411,468.6711,129.7812,177.9911,318.1710,682.7410,416.94
Inventories11,995.839,765.8010,677.559,562.569,910.7010,219.098,973.268,547.338,187.05
Other Current Assets2,370.041,535.651,244.941,690.522,233.461,814.52889.02951.10655.64
Total Current Assets36,351.5830,132.0133,863.0536,314.2534,757.3841,237.3132,115.8528,097.4831,645.88
Net Property, Plant & Equipment13,519.0912,012.8413,050.3412,469.7513,619.1112,924.3612,366.5811,032.5411,502.46
Total Investments and Advances8,057.903,374.692,945.002,950.952,757.712,604.945,952.626,344.486,534.75
Long-Term Note Receivable461.56519.82652.85482.40551.54657.05768.91708.75839.36
Intangible Assets79,347.0268,356.4681,438.1176,342.5378,993.3276,722.7068,574.6575,589.6564,055.48
Deferred Tax Assets10,109.678,249.837,099.595,742.875,228.855,109.546,099.665,273.355,152.63
Other Assets1,079.3214,866.67649.53941.31831.29734.13667.89309.79124.88
Total Assets148,926.13137,512.33139,698.46135,244.05136,739.20139,990.03126,546.16127,356.06119,855.45
Short Term Debt Incl. Current Port. of LT Debt5,418.914,628.692,562.794,750.333,925.613,669.435,404.843,009.911,531.02
Accounts Payable8,645.137,819.068,094.887,271.177,027.906,478.705,963.845,762.625,563.31
Income Tax Payable882.01721.74659.48612.60838.121,163.60688.09837.931,416.94
Other Current Liabilities18,343.7314,821.1115,408.7612,941.4712,425.0512,239.1710,820.9010,252.9110,056.70
Total Current Liabilities33,289.7927,990.6026,725.9025,575.5824,216.6723,550.8922,877.6719,863.3718,567.97
Long Term Debt18,456.4813,912.9817,787.0717,888.1821,563.5925,298.1223,704.9625,157.3017,202.66
Provision for Risks Charges5,333.185,966.555,812.676,213.537,312.208,562.408,253.747,868.308,643.36
Deferred Tax Liabilities1,956.632,242.892,051.341,964.811,838.852,165.682,575.013,902.711,927.28
Other Liabilities5,670.246,778.385,187.443,395.993,305.843,020.942,786.053,078.503,580.79
Total Liabilities64,706.3256,891.4157,564.4255,038.0858,237.1562,598.0460,197.4359,870.1949,922.06
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity83,827.5480,258.5081,788.2979,813.2278,104.0377,213.3566,153.4167,304.1069,730.46
Total Shareholders Equity83,827.5480,258.5081,788.2979,813.2278,104.0377,213.3566,153.4167,304.1069,730.46
Accumulated Minority Interest392.27362.43345.76392.75398.02178.64195.31181.76202.94
Total Equity84,219.8180,620.9282,134.0480,205.9778,502.0577,391.9866,348.7367,485.8669,933.39
Total Liabilities & Stockholders Equity148,926.13137,512.33139,698.46135,244.05136,739.20139,990.03126,546.16127,356.06119,855.45
Book Value Per Share34.7132.0132.6831.8631.1830.8726.3827.0227.81
Tangible Book Value Per Share1.864.750.141.39-0.350.20-0.97-3.332.26
Full-Time Employees76,49384,58787,99491,57395,44299,412100,409104,226106,566
Price to Book Ratio1.491.551.571.631.611.581.901.611.64
Return on Assets3.894.293.986.475.3110.522.564.123.70
Return on Equity6.797.346.7711.149.4819.554.887.446.53
Return on Invested Capital5.746.395.869.007.3813.673.625.514.90
Quick Ratio0.730.730.871.051.031.321.010.981.26
Current Ratio1.091.081.271.421.441.751.401.411.70

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income5,046.998,817.586,014.205,838.028,797.717,355.4714,014.853,140.615,080.00
Depreciation8,038.496,408.073,878.944,788.263,866.533,687.783,717.464,163.604,058.34
Other Funds (Non Cash)1,420.45-2,366.631,462.451,350.31-251.18148.93-8,653.553,794.25-226.51
Funds from Operations11,995.8310,106.4210,488.0710,643.5811,805.5910,771.398,826.829,136.438,054.15
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital2,074.702,025.80-665.24446.50-743.041,665.41-370.49-468.97-1,510.08
Cash from Operating Activities14,070.5312,132.219,822.8311,090.0811,062.5612,436.808,456.338,667.466,544.07
Capital Expenditures-4,182.75-4,083.20-3,499.27-3,383.89-2,330.01-2,495.16-2,503.38-2,032.56-2,332.37
Net Assets From Acquisitions0.000.000.00-3.24-1,042.57-6,612.00-6,082.90-554.03-15,258.88
Sale of Fixed Assets and Businesses1,008.40955.911,580.35872.461,704.68848.661,046.501,369.962,551.80
Purchase or Sale of Investments-12,475.81-11,373.81-2,730.19-2,840.09-512.88-367.6011,665.36-42.53-161.63
Purchase of Investments-12,566.80-11,373.81-2,730.19-2,885.50-512.88-367.60-156.18-42.53-161.63
Sale Or Maturity of Investments90.990.000.0045.410.000.0011,821.530.000.00
Other Uses-259.29-40.63-117.90-1,351.390.000.000.00-105.21-75.50
Other Sources441.1111,780.100.000.000.000.000.00172.360.00
Cash from Investing Activities-15,468.35-2,761.63-4,767.01-6,706.16-2,180.77-8,626.104,125.57-1,192.00-15,276.58
Cash Dividends Paid-6,096.10-5,385.57-5,088.27-4,815.29-4,380.46-4,737.38-4,488.08-4,291.20-4,451.20
Change in Capital Stock-2,475.48-5,476.99-124.39-430.28-324.75-231.67-705.64171.25-1,090.09
Repurchase of Common Pref Stock-2,671.23-5,676.75-326.67-641.10-522.33-451.52-937.06-10.07-1,298.90
Sale of Common Pref Stock195.75199.76202.28210.82197.58219.85231.41181.32208.82
Proceedsfrom Stock Options195.75199.76202.28210.82197.58219.85231.41181.32208.82
Issuance or Reduction of Debt, Net488.152,073.20-662.00-3,117.94-1,002.63-3,138.16-1,882.10-250.7110,289.80
Change in Long Term Debt3,118.783,314.63-725.81-3,929.86-1,228.59-2,648.82-2,203.57-78.3510,487.98
Issuance of Long Term Debt5,901.896,273.76-51.891,627.96-2,301.612,235.1411,416.44
Reduction of Long Term Debt-2,783.12-2,959.13-725.81-3,981.75-2,856.55-2,648.82-4,505.18-2,313.49-928.46
Net Financing Active Other Cash Flow-47.55-97.06-54.08-64.87-104.05-56.74-50.16-15.67-16.52
Other Financing Activities Uses-47.55-97.06-54.08-64.87-104.05-56.74-50.16-15.67-16.52
Cash from Financing Activities-8,555.38-9,262.24-6,233.78-8,701.90-6,117.72-8,340.06-7,392.73-4,685.174,731.98
Exchange Rate Effect13.22-53.04-14.06-34.608.4117.73-72.9610.071.18
Net Change in Cash-9,939.9855.30-1,192.02-4,352.572,772.47-4,511.625,116.212,800.36-3,999.35
Free Cash Flow12,054.7210,143.667,948.269,339.768,749.3610,022.026,081.766,634.914,211.71
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow17.2624.9642.3627.6227.8723.8576.8453.85-
Deferred Taxes & Investment Tax Credit--2,752.60-867.52-1,333.02-607.46-420.79-251.93-1,962.04-857.68

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Cash & Short Term Investments7,259.959,012.7318,029.167,824.247,282.549,621.50
Short Term Receivables10,525.2212,972.979,633.7911,006.339,436.7612,195.34
Inventories12,721.5011,995.8311,290.099,765.8011,370.2010,677.55
Other Current Assets5,532.432,370.044,499.371,535.654,147.671,368.66
Total Current Assets36,039.1036,351.5843,452.4130,132.0132,237.1733,863.05
Net Property, Plant & Equipment13,667.0113,519.0912,920.5712,012.8412,732.3913,050.34
Total Investments and Advances8,151.738,057.908,218.123,374.692,829.422,945.00
Intangible Assets78,102.2579,347.0271,269.1368,356.4682,238.5981,438.11
Deferred Tax Assets10,018.7410,109.679,400.198,249.837,806.637,099.59
Other Assets1,094.141,079.32974.3014,866.67590.53649.53
Total Assets147,554.30148,926.13146,683.12137,512.33139,064.92139,698.46
Short Term Debt Incl. Current Port. of LT Debt8,292.355,418.918,875.484,628.6910,197.702,562.79
Accounts Payable8,174.608,645.138,304.997,819.067,966.328,094.88
Income Tax Payable1,010.68882.01849.87721.74141.47659.48
Other Current Liabilities19,027.9418,343.7316,080.5714,821.1113,875.9515,408.76
Total Current Liabilities36,505.5733,289.7934,110.9127,990.6032,181.4426,725.90
Long Term Debt18,662.0918,456.4817,283.7713,912.9815,257.4317,787.07
Deferred Tax Liabilities1,775.541,956.632,013.152,242.891,929.152,051.34
Other Liabilities5,825.115,670.244,905.526,778.385,119.755,187.44
Total Liabilities68,018.3564,706.3264,186.1256,891.4160,830.3957,564.42
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity79,124.3683,827.5482,178.8980,258.5077,905.5181,788.29
Total Shareholders Equity79,124.3683,827.5482,178.8980,258.5077,905.5181,788.29
Accumulated Minority Interest411.59392.27318.11362.43329.03345.76
Total Equity79,535.9584,219.8182,497.0080,620.9278,234.5382,134.04
Total Liabilities & Stockholders Equity147,554.30148,926.13146,683.12137,512.33139,064.92139,698.46
Book Value Per Share32.5934.7133.7632.0131.1432.68
Tangible Book Value Per Share0.421.864.484.75-1.730.14
Price to Book Ratio1.491.441.511.551.481.57
Return on Assets3.123.874.704.293.314.25
Return on Equity5.706.768.397.345.807.22
Return on Invested Capital2.312.383.423.812.612.14
Quick Ratio0.640.730.940.730.650.87
Current Ratio0.991.091.271.081.001.27

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S22025S12024S22024S12023S2
Net Income2,282.832,764.166,347.783,591.132,427.612,135.12
Depreciation3,359.504,678.991,943.002,320.031,561.842,034.81
Other Funds (Non Cash)716.23704.23-3,149.86217.321,246.231,932.60
Funds from Operations6,104.265,891.574,552.226,103.374,392.615,535.16
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-688.232,762.93-669.512,188.80-2,854.551,711.47
Cash from Operating Activities5,416.038,654.513,882.728,292.181,538.067,246.63
Capital Expenditures-1,549.10-2,633.65-1,585.85-1,419.09-2,082.81-2,281.71
Net Assets From Acquisitions0.000.000.000.000.00-0.00
Sale of Fixed Assets and Businesses494.59513.81474.01925.46656.08473.41
Purchase or Sale of Investments-1,771.90-10,703.91-1,049.59-470.01-2,262.24-1,578.01
Purchase of Investments-1,862.89-10,703.91-1,049.59-470.01-2,262.24-1,607.23
Sale Or Maturity of Investments90.990.000.000.000.0029.23
Other Uses-256.63-2.67-39.32-117.990.000.00
Other Sources0.00441.1111,732.240.000.000.00
Cash from Investing Activities-3,083.04-12,385.319,531.49-1,081.64-3,688.97-3,386.31
Cash Dividends Paid-5,742.64-353.46-5,211.90-7.75-5,084.35-5.25
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-1,155.99-1,319.49-4,340.34179.23-303.72-71.79
Repurchase of Common Pref Stock-1,176.99-1,494.24-4,372.01-0.50-326.42-249.23
Sale of Common Pref Stock21.00174.7531.67179.7322.70177.45
Proceedsfrom Stock Options21.00174.7531.67179.7322.70177.45
Issuance or Reduction of Debt, Net3,212.52-2,724.374,866.77-6,335.925,673.42-2,836.68
Change in Long Term Debt932.032,186.751,238.54-37.86-688.51-1,037.33
Issuance of Long Term Debt2,687.603,214.293,268.91--51.92
Reduction of Long Term Debt-1,755.57-1,027.54-2,030.37-37.86-688.51-1,089.25
Net Financing Active Other Cash Flow-29.16-18.38-81.91-20.62-33.51-13.04
Other Financing Activities Uses-29.16-18.38-81.91-20.62-33.51-13.04
Cash from Financing Activities-3,886.75-4,668.62-4,902.82-6,334.6896.20-3,076.20
Exchange Rate Effect22.16-8.94-45.871.06-15.13-14.09
Net Change in Cash-1,531.61-8,408.378,465.52876.92-2,069.84770.03
Free Cash Flow3,904.258,150.472,331.818,454.69-500.446,392.02
Price to Free Cash Flow17.2623.8721.3642.39151.7128.35

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.52%12.3M2383.5M3.06M
2026-10-150.49%11.6M2383.5M2.98M
2026-09-300.45%10.6M2383.5M2.85M
2026-09-150.39%9.3M2383.5M3.27M
2026-08-310.35%8.2M2383.5M3.30M
2026-08-140.31%7.3M2383.5M3.38M
2026-07-310.43%10.2M2383.5M3.37M
2026-07-150.31%7.4M2404.3M3.17M
2026-06-300.28%6.6M2404.3M3.10M
2026-06-150.27%6.4M2404.3M2.77M
2026-05-290.28%6.7M2404.3M3.08M
2026-05-150.27%6.5M2400.5M3.39M
2026-04-300.33%7.9M2400.4M3.89M
2026-04-150.32%7.6M2400.4M4.05M
2026-03-310.31%7.4M2400.2M4.23M
2026-03-130.31%7.3M2400.2M3.98M
2026-02-270.27%6.6M2414.9M3.65M
2026-02-130.33%7.9M2414.9M3.38M
2026-01-300.35%8.3M2417.7M2.75M
2026-01-150.35%8.5M2417.7M2.65M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call25.0021.3024.800.003.8730.000.000.990-0.0170.002
call27.5018.8022.600.003.6560.000.000.988-0.0170.002
call30.0016.3019.6018.402.85914.000.000.986-0.0160.002
call32.5013.8017.600.002.8220.000.000.984-0.0160.003
call35.0011.3014.906.502.3299.000.000.982-0.0160.003
call37.5010.5011.3010.301.2732500.000.978-0.0150.004
call40.008.008.807.111.0212820.000.956-0.0260.007
call42.505.506.305.760.7732,9001.000.926-0.0330.010
call45.003.103.703.300.4703,6003.000.871-0.0370.016
call47.501.201.601.050.3632,7921.000.649-0.0540.028
call50.000.250.500.300.28626819.000.268-0.0450.025
call52.500.000.600.050.44048.000.000.133-0.0410.016
call55.000.000.250.000.4520.000.000.038-0.0160.006
call60.000.002.100.000.7780.000.000.044-0.0310.007
put25.000.000.750.041.9282.000.00-0.009-0.0210.002
put27.500.002.150.001.6750.000.00-0.011-0.0200.002
put30.000.002.150.001.4420.000.00-0.012-0.0200.002
put32.500.000.050.051.15419.000.00-0.015-0.0170.003
put35.000.000.050.050.9611940.00-0.017-0.0170.003
put37.500.000.050.040.8328752.00-0.021-0.0180.004
put40.000.000.100.080.7372,6650.00-0.042-0.0280.007
put42.500.000.150.100.5947750.00-0.073-0.0350.010
put45.000.000.200.050.42046743.00-0.128-0.0380.016
put47.500.450.600.850.33444830.00-0.350-0.0550.028
put50.001.602.158.000.3930.000.00-0.730-0.0460.025
put52.503.804.600.000.6100.000.00-0.866-0.0420.016
put55.006.207.000.000.7540.000.00-0.961-0.0160.006
put60.009.8013.700.001.8870.000.00-0.973-0.0180.005

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0513F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-09-30SEC
2026-10-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-30SEC
2026-10-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-26SEC
2026-10-26SCHEDULE 13G/ASEC
2026-10-016-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-01SEC
2026-09-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-17SEC
2026-08-25N-PXAnnual Report of Proxy Voting Record of Registered Management Investment Companies filed on Form N-PX2026-06-30SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-123Initial statement of beneficial ownership of securities2026-08-06SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-066-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-06SEC
2026-08-043Initial statement of beneficial ownership of securities2026-08-04SEC
2026-07-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-07-306-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-07-2813F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-06-30SEC
2026-07-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-27SEC
2026-07-22SCHEDULE 13G/ASEC
2026-07-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-17SEC
2026-07-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-07SEC
2026-06-3011-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-3011-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-06-30NT 11-K2025-12-31SEC
2026-06-30NT 11-K2025-12-31SEC
2026-06-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-24SEC
2026-06-226-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-22SEC
2026-06-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-12SEC
2026-06-086-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-08SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-27SEC
2026-05-0713F-HRFurther understand that each of 13F-HR, 13F-NT, and amendments thereto are mandatory electronic filings (hardship exemption exists to submit in paper; never used to the knowledge of IM staff);2026-03-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
DODGE & COX1.17%
MORGAN STANLEY0.45%
Fisher Asset Management, LLC0.40%
BANK OF AMERICA CORP /DE/0.33%
Invesco Ltd.0.28%
JPMORGAN CHASE & CO0.27%
Mondrian Investment Partners LTD0.24%
BRANDES INVESTMENT PARTNERS, LP0.17%
Boston Partners0.17%
FMR LLC0.17%

Funds

Fund% owned
Dodge & Cox Stock Fund0.87%
Invesco Comstock Fund0.17%
Putnam Focused Large Cap Value ETF0.14%
Dodge & Cox Balanced Fund0.07%
American Mutual Fund0.07%
Blackstone Alternative Multi-Strategy Fund0.06%
Nicholas Fund, Inc.0.06%
Equity Income Fund0.04%
Bridge Builder Large Cap Value Fund0.04%
VanEck Pharmaceutical ETF0.03%

OakChart. SNY. Cached 15 minutes.

Some panels did not load: insider.